TAIKO PHARMACEUTICAL CO.,LTD.

4574

TSE PrimePharmaceuticals

¥ -

You can review earnings summary, quarterly trends, full-year progress, and detailed income statement data.

descriptionIncome Statement (PL) Summary

Updated: 2026-08-13FY2026 Q2

Revenue

66.2100M JPY

YoY +13.3%

Operating Income

17,000,000JPY

YoY -63.0%

Net Income

6.9100M JPY

YoY +66.6%

EPS

0.9JPY

YoY -84.0%

Performance Trend

Revenue, operating income and net income trend (last 5 periods)

RevenueOperatingNet Income

113億円

60.8億円

8.5億円

-43.7億円

-95.9億円

Rev: 113億円Op: -49.5億円NI: -95.9億円

Rev: 50.4億円Op: -30.8億円NI: -49億円

Rev: 61.2億円Op: -10.1億円NI: -36.1億円

Rev: 62.9億円Op: 6.3億円NI: 9億円

Rev: 64億円Op: 4.6億円NI: 9.2億円

2021/FY2022/FY2023/FY2024/FY2025/FY

Full-Year Progress

FY2026 Q2

Net Income8%

Revenue Progress26.400M

Revenue Forecast7200M

Net Income Progress44M

Net Income Forecast5.500M

Income Statement Details

Unit: JPY

Unlock Long-Term Financial Data

Your current plan allows viewing financial data for the latest 1 year (annual only). Upgrade to the Standard Plan to view up to 3 years (including quarterly data), or the Premium Plan to access all historical data.

Standard Plan Premium Plan